Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon A Mahal

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Cancer|July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
Nature Reviews. Urology|October 18, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwardsEdward Christopher Dee, Rebecca Todd, Kenrick Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
Cancer|June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national databaseAmandeep R Mahal, Santino Butler, Idalid Franco, et al.
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
The Prostate|April 1, 2025
Treatment Noncompletion and Shorter Radiation Regimens Among US Patients With Prostate Cancer: A Focus on Asian American and Pacific Islander PatientsRohit V Mantena, Rishabh Bhadouriya, Urvish Jain, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Cancer|July 20, 2016
National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?Brandon A Mahal, Yu-Wei Chen, Vinayak Muralidhar, et al.
Nature Reviews. Urology|October 18, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwardsEdward Christopher Dee, Rebecca Todd, Kenrick Ng, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
Cancer|June 29, 2019
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national databaseAmandeep R Mahal, Santino Butler, Idalid Franco, et al.
Urology|July 1, 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groupsBrandon A Mahal, Ayal A Aizer, David R Ziehr, et al.
The Prostate|April 1, 2025
Treatment Noncompletion and Shorter Radiation Regimens Among US Patients With Prostate Cancer: A Focus on Asian American and Pacific Islander PatientsRohit V Mantena, Rishabh Bhadouriya, Urvish Jain, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Pageof 22